| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |